Jessie J shared she’s “healing” after undergoing her second breast cancer reconstruction surgery one year after the first: “Talk to me nice.”

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer with apalutamide - a next-generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) - plus hormone therapy before and after prostate cancer surgery,

Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 INTerpath-001 trial presented at the ESMO Congress 2026.

Most women assume Medicare stops covering reconstruction at the healthy breast, and that assumption can cost thousands of dollars in bills they never needed to pay.

The cohort met its primary endpoint of major pathologic response, with 83% of patients having little or no cancer remaining at surgery in a high-risk, locally advanced population;